Skip to content
Storytelling Co – Lifestyle
Author:
AlzeCure Pharma
AlzeCure Pharma to Present at Aktiespararna in Stockholm on 14 October
October 8, 2026
AlzeCure Pharma to Present at Swiss Nordic Bio 2026 in Zurich
September 22, 2026
AlzeCure Pharma Publishes Updated Company Presentation Following the Eli Lilly and QuantumCell Agreements
September 18, 2026
AlzeCure Pharma to Present at Aktiedagen Stockholm on Sept 15
September 8, 2026
AlzeCure Pharma to Present at The Pareto Securities 17th Annual Healthcare Conference on September 2
August 27, 2026
AlzeCure Receives a USD 10 Million Upfront Payment and Completes Initial Transaction with Lilly
August 18, 2026
AlzeCure Receives a Total Upfront Payment of USD 12 million and Completes the Initial Transaction with QuantumCell
August 12, 2026
AlzeCure Pharma Resolves on a Directed Share Issue to QuantumCell
August 3, 2026
Final Outcome of AlzeCure’s Rights Issue
July 2, 2026
AlzeCure Pharma Enters an Out-Licensing and Collaboration Agreement with QuantumCell ApS for the NeuroRestore ACD856 Project
July 1, 2026
1
2
3
Next Page
→